Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.61% | 185.71 | 0.0% | $901.88m | |
| AMGN | Amgen, Inc. | -0.28% | 245.55 | 1.5% | $590.34m | |
| NVAX | Novavax, Inc. | -2.07% | 59.02 | 75.7% | $452.24m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.03% | 291.00 | 1.9% | $424.20m | |
| GILD | Gilead Sciences, Inc. | 0.34% | 61.30 | 1.0% | $373.56m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.02% | 613.51 | 2.6% | $344.39m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 3.87 | 0.7% | $270.53m | |
| ILMN | Illumina, Inc. | 0.64% | 225.19 | 3.3% | $243.06m | |
| BIIB | Biogen, Inc. | 0.83% | 220.00 | 1.8% | $202.89m | |
| GOVX | GeoVax Labs, Inc. | 2.80% | 3.31 | 0.0% | $164.90m | |
| BNTX | BioNTech SE | -6.67% | 170.90 | 0.0% | $143.09m | |
| CRSP | CRISPR Therapeutics AG | -0.82% | 80.73 | 0.6% | $131.68m | |
| MRTX | Mirati Therapeutics, Inc. | 8.60% | 94.00 | 1.6% | $101.56m | |
| PLRX | Pliant Therapeutics, Inc. | 3.12% | 19.50 | 0.0% | $98.38m | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 5.63% | 21.38 | 0.0% | $96.44m |
Company Profile
IMV, Inc. is a clinical-stage biopharmaceutical company, which engaged in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The firm leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities. Its drug candidate, DPX-Survivac is a targeted T cell therapy that has completed multiple phases 1 and 1b trials generating results in late-stage ovarian cancer and relapsed/refractory DLBCL (Diffuse Large B Cell Lymphoma) where it has identified a predictive biomarker. The company was founded by Warwick Kimmins and Brian E. Lowe on May 18, 2007 and is headquartered in Dartmouth, Canada.